Treatment of Depression - Search News

FDA-Approved Nasal Spray For Depression Is 1st Of Its Kind

FDA-approved nasal spray for severe depression can lead to remission

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in people who have not responded to at least two oral antidepressants.

Popular Science · 5d

FDA approves first-of-its-kind nasal spray for severe depression

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and similar psychiatric conditions.

Hosted on MSN · 5d

FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatment

Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a blockbuster product.

22h

How Brain Signals Could Revolutionize Personalized Depression Treatment

Scientists at Virginia Tech are revolutionizing depression treatment by tapping into how the brain processes rewards. Their ...

Association for Psychological Science11d

Treatment Could Provide Relief for Comorbid Depression and Anxiety

For people with anxiety and depression, these conditions can feel like two sides of the same coin. Researchers are exploring ...

Psychology Today1d

Preventive Mental Health Care for Postpartum Depression

Postpartum depression affects many new mothers, increasing suicide risk. New research shows preventive cognitive behavioral ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results